Search for: "v. Teva Pharmaceuticals USA, Inc."
Results 21 - 40
of 440
Sorted by Relevance
|
Sort by Date
14 Oct 2014, 9:59 pm
By Andrew Williams -- On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
1 Sep 2015, 9:59 pm
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
25 Jun 2017, 9:25 pm
District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc., USA and Teva Pharmaceuticals USA, Inc. to a Report and Recommendation issued by Magistrate Judge Burke and adopted the Report. [read post]
23 Nov 2018, 8:03 pm
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
16 Sep 2013, 9:59 pm
Teva Pharmaceuticals USA. [read post]
24 Apr 2024, 9:27 pm
Teva Pharmaceuticals USA, Inc. [read post]
26 Jun 2018, 8:51 pm
Teva Pharmaceuticals USA Inc., Docket No. 17-1229.... [read post]
31 Mar 2014, 8:47 pm
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]
7 Jun 2018, 4:59 pm
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
26 Jan 2010, 9:59 pm
Teva Pharmaceuticals USA, Inc., Proctor & Gamble Co. v. [read post]
17 Oct 2018, 7:49 pm
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
24 Jun 2015, 9:59 pm
Teva Pharmaceuticals USA, Inc. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
13 Oct 2014, 8:46 pm
Teva Pharmaceuticals USA, Inc. et al. v. [read post]
22 Jan 2019, 9:50 pm
Teva. [read post]
9 Oct 2014, 9:59 pm
By Andrew Williams -- Next week, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
7 Dec 2021, 8:33 am
Inc. v. [read post]
18 Dec 2009, 9:59 am
Teva Pharmaceuticals USA, Inc. [read post]
